JacquelineMarieLaurinMD

Hepatology & Liver Transplantation

Johns Hopkins Gastroenterology & Hepatology

Dr. Laurin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
5215 Loughboro Road Northwest
Washington, DC 20016
Phone+1 202-660-5555

Fax+1 202-660-6103

Dr. Jacqueline Laurin is a hepatologist & gastroenterologist in Washington, DC and is affiliated with multiple hospitals in the area, including Sibley Memorial Hospital, Suburban Hospital, and Johns Hopkins Hospital. She received her medical degree from University of Florida College of Medicine and has been an attending in academic medicine and clinical practice since 1994. She specializes in general and transplant hepatology and is experienced in managing acute and chronic liver diseases, cirrhosis, liver tumors, transplant patients and biliary tract diseases. Dr. Laurin performs screening colonoscopy and upper endoscopy including variceal band ligation.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 1993 - 1994
University of MarylandFellowship, Gastroenterology, 1991 - 1993
University of MarylandResidency, Internal Medicine, 1989 - 1991
University of FloridaInternship, Internal Medicine, 1988 - 1989
University of Florida College of MedicineClass of 1988

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

PubMed

48 citations
Dobutamine stress echocardiography in patients undergoing orthotopic liver transplantation: a pooled analysis of accuracy, perioperative and long term cardiovascular p...
Peter Nguyen, Jeff Plotkin, Thomas M. Fishbein, J. Laurin, Rohit Satoskar
The International Journal of Cardiovascular Imaging. 2013-08-23
423 citations
Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Jacqueline M. Laurin, Keith D. Lindor, Jeffrey S. Crippin, Andrea A. Gossard, Gregory J. Gores
Hepatology. 1996-06-01
21 citations
Use of adjuvant sorafenib in liver transplant recipients with high-risk hepatocellular carcinoma.
Kirti Shetty, Chiranjeev Dash, J. Laurin
Journal of Transplantation. 2014-04-10

Journal Articles

Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival Following Liver Transplantation for Hepatitis C Virus
Jesudian A, Desale S, Julia J, Landry E, Maxwell C, Kallakury B, Laurin J, Shetty K., J Clin Exp Hepatol. 2016 Jun;6(2):109-14., 6/2016
Use of Adjuvant Sorafenib in Liver Transplant Recipients With High-Risk Hepatocellular Carcinoma
Shetty K, Dash C, Laurin J., J Transplant. 2014;2014:913634., 2014
Motion - All Patients With NASH Need to Have a Liver Biopsy: Arguments Against the Motion
Laurin J., Can J Gastroenterol. 2002 Oct;16(10):722-6, 10/2002